Furthermore, it was also considered that GALNT2 can inhibit cancer development by reducing MET phosphorylation in some conditions [45], and it was found that cg17737409 site methylation in GLANT2 was helpful for patient's prognosis in this study. This evidence concerns the gene MET and cancer.